Advertisement: TTP Killer 50
21 August, 2020 - 18:30 By Tony Quested

Tristel handed keys to India market

Anti-infection technology from Tristel in Newmarket has been handed a major commercial boost for the ultrasound probe and gynaecological  markets in India.

Tristel’s Duo high-level disinfectants, branded Duo ULT, Duo OPH and Duo EVE, have been approved for the decontamination of semi-critical medical devices by India’s Medical Device & Diagnostics Division, Central Drugs Standard Control Organisation (CDSCO).

Duo ULT is intended for use on invasive ultrasound probes; Duo OPH is intended for use on ophthalmic instruments; and Duo EVE is intended for use on Mobile ODT’s hand-held EVA colposcope and associated instruments used in gynaecological procedures.

In 2019 the Company received regulatory approvals from the CDSCO for Stella, which is an instrument soaking system for urological instruments, and Rinse Assure which is used with endoscope washer-disinfectors. Tristel incorporated Tristel India Private Limited during its 2018 financial year.

Duo is a hand-held dispenser which applies the company’s powerful chlorine dioxide chemistry as a foam to the surface of medical devices. 

Tristel Duo is widely used throughout Europe, the Middle East and the Asia-Pacific region and the company is seeking approval for Duo ULT from the United States Food and Drug Administration. 

Worldwide sales of all Duo branded products for medical device disinfection were £3.9 million in the 2020 financial year, an increase of 56 per cent on the prior year.

Paul Swinney, CEO of Tristel said: “Every regulatory approval we achieve represents an important milestone in our progress, and this Indian approval for the use of our high-level disinfectants on invasive medical devices is no exception.

“The three Duo products provide Indian hospitals with an affordable and easy-to-use high-level disinfection method for medical devices used in ultrasound, ophthalmology, and gynaecology. 

“Infection prevention experts within India acknowledge the need for disinfection technologies that will enable hospitals to raise their decontamination standards. 

“Combining these latest approvals with those previously gained gives us a broad product offering for the Indian market.  
 
“We can now press on with developing our commercial plan for India. We have initiated discussions with various potential partners for distribution of the products.”

Newsletter Subscription

Stay informed of the latest news and features